RxDoctor Payments DataLook up a doctor →

Veronique Sebastian, MD

Psychiatry · Oklahoma City, OKNPI 1740371129

Payments from drug & device makers

$3,759,241in general payments, 2019–2025

Across 776 payments — averaging $4844.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.8M
  • Sage Therapeutics, LLC$379K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$359K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$232K
  • Sumitomo Pharma America, Inc.$212K
  • Boehringer Ingelheim International GmbH$197K
  • plus $590K from 10 others

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,759,241 in reported general payments places this provider in the 95th percentile of 328 psychiatry providers in Oklahoma.

See all psychiatry providers in Oklahoma

Medicare billing

Part B allowed, 2024
$4,519
Medicare patients
12
Services billed
50

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl16$22,723
Duloxetine Hcl66$1,440
Quetiapine Fumarate34$789
Modafinil13$442
Zolpidem Tartrate57$434
Mirtazapine24$407
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine11$371
Clonazepam38$335
Armodafinil15$318
Aripiprazole19$274
Gabapentin13$219
Lorazepam23$211
Venlafaxine Hcl ErVenlafaxine Hcl14$204
Trazodone Hcl12$192
Fluoxetine Hcl24$148

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,790,772$22,72316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 328 psychiatry providers in Oklahoma.

Other psychiatry in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →